Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$0.01
C$0.01
C$0.01
C$0.02
C$1.85MN/A317,764 shs26,000 shs
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
C$0.02
-25.0%
C$0.02
C$0.02
C$0.10
C$984K1.5152,289 shs4,000 shs
PBS
Invesco Next Gen Media and Gaming ETF
$57.55
-0.6%
$53.45
$30.95
$40.10
$139.27M1.225,287 shs7,855 shs
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
C$0.03
C$0.02
C$0.01
C$0.14
C$1.52M1.577,594 shs3,159 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
0.00%0.00%0.00%0.00%0.00%
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
0.00%0.00%0.00%0.00%0.00%
PBS
Invesco Next Gen Media and Gaming ETF
-0.78%+1.68%+3.32%+11.16%+19.19%
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
0.00
N/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
0.00
N/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
2.70
Moderate Buy$57.55N/A
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$2.23M0.83C$0.00 per share10.00C($0.07) per share-0.15
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AC$0.00 per share55.00C($0.02) per shareN/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/AN/AN/AN/A
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
C$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A-C$0.01N/AN/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/A-C$0.01N/AN/AN/AN/A-340.40%N/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/A30.67N/AN/AN/AN/AN/A
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
-C$2.26M-C$0.04N/AN/AN/AN/A-143.12%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
$0.070.12%N/AN/AN/A
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A
0.04
0.03
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
882.79
0.03
0.17
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/A
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
N/AN/A
0.02
CompanyEmployeesShares OutstandingFree FloatOptionable
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
4,800184.98 millionN/ANot Optionable
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
665.59 millionN/ANot Optionable
PBS
Invesco Next Gen Media and Gaming ETF
N/A2.42 millionN/ANot Optionable
Solarvest BioEnergy Inc. stock logo
SVS
Solarvest BioEnergy
N/A60.76 millionN/ANot Optionable

Recent News About These Companies

Solarvest order book to surpass RM2bil in FY26
Solarvest order book hits record RM1.4bil
Solarvest maintains sunny outlook
Solarvest unit wins RM103mil EPCC contract
Solarvest bags EPCC deal valued at RM401mil
Solarvest’s prospects brighten with new projects
Solarvest net profit jumps 35% in 3Q25

Media Sentiment Over Time

Top Headlines

View All Headlines
Medifocus Inc. (MFS.V) stock logo

Medifocus Inc. (MFS.V) CVE:MFS

C$0.01 0.00 (0.00%)
As of 09/4/2020

Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.

Pascal Biosciences stock logo

Pascal Biosciences CVE:PAS

C$0.02 -0.01 (-25.00%)
As of 12/5/2022

Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.

Invesco Next Gen Media and Gaming ETF NYSEARCA:PBS

$57.55 -0.34 (-0.58%)
As of 06/20/2025

PowerShares Dynamic Media Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Media Intellidex Index (the Index). The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Solarvest BioEnergy stock logo

Solarvest BioEnergy CVE:SVS

C$0.02 0.00 (0.00%)
As of 09/5/2023

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.